Description of Biomx Inc's Business Segments

The Company operates as a single segment focused on clinical-stage product discovery using natural and engineered phage technologies. The chief executive officer serves as the chief operating decision-maker, reviewing consolidated financial information and monitoring net loss and operating loss to assess segment performance and allocate resources. Major expenses include research and development salaries and related costs, general and administrative salaries and related costs, clinical trials, stock-based compensation, depreciation, goodwill, in-process research and development (IPR&D), impairment of long-lived assets, external professional services, rent, insurance, and other administrative expenses, net of grants received. The Company's property, equipment, and operating lease right-of-use assets are located in Israel and the United States.

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Composition of Biomx Inc Revenues by Segments


All Other Segments		100 %	of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments	Revenues (in millions $)	% (of total Revenues)
All Other Segments	0.33	100 %
Total	0.33	100 %

Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment	Y/Y Revenue %	Q/Q Revenue %
All Other Segments	-	-
Total	-	-

Q2 three months ended (Jun 30 2026)
Income by Business Segments	Income (in millions $)	% (Profit Margin)
Total	-3.85	-

Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment	Y/Y Income %	Q/Q Income %
Total	-	-

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.